Revelation Biosciences, Inc. (REVB) financial statements and ratios from SEC XBRL: revenue $222.00 (TTM), net margin -959741.0%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $222.00 |
| Net Margin | -959741.0% |
| Price / Book | 0.43 |
| FCF Yield | -288.2% |
| Sector P/E (Healthcare) | 21.7 |
REVB overview · REVB earnings · REVB KPIs · REVB investor relations · REVB ownership · REVB peers · REVB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.